Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease

Medical Ultrasonography

Volumn 17, Issue 3, 2015, Pages 300-307

  Silaghi, Cristina Alina ^a,b   Silaghi, Horaţiu ^a   Crăciun, Anca Elena ^a,c   Fărcaş, Anca ^a,c   Colosi, Horaţiu Alexandru ^a   Cosma, Daniel Tudor ^a,b   Pais, Raluca ^d   Hâncu, Nicolae ^c   Georgescu, Carmen Emanuela ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Clinical Emergency County Hospital   (Romania)

^c Regina Maria Clinic   (Romania)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Carotid intima media thickness; Glycated hemoglobin; Nonalcoholic fatty liver disease; Type 2 diabetes; Visceral adipose tissue

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ABDOMINAL OBESITY; ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; BODY COMPOSITION; CAROTID ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; CAROTID ARTERY DISEASES; COMPLICATION; IMPEDANCE; LIVER FUNCTION TEST; METABOLISM; MIDDLE AGED; RISK FACTOR;

AGE FACTORS; BODY COMPOSITION; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; DIABETES MELLITUS, TYPE 2; ELECTRIC IMPEDANCE; FATTY LIVER; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84941269822     PISSN: 18444172     EISSN: 20668643     Source Type: Journal    
DOI: 10.11152/mu.2013.2066.173.cas     Document Type: Article

References (50)

1. Tilg H, Kaser A. Treatment strategies in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 148-155.
2. Williamson RM, Price JF, Glancy S, et al. Edinburgh Type 2 Diabetes Study Investigators. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2011; 34: 1139-1144.
3. Gupte P, Amarapurkar D, Agal S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854-858.
4. Pais R, Charlotte F, Fedchuk L, et al. LIDO Study Group. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol 2013; 59: 550-556.
5. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923.
6. Targher G, Bertolini L, Rodella S, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007; 30: 2119-2121.
7. Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008; 49: 600-607.
8. O'Leary DH, Polak JF. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 2002; 90: 18L-21L.
9. Targher G, Bertolini L, Padovani R, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29: 1325-1330.
10. Lakka TA, Lakka HM, Salonen R, Kaplan GA, Salonen JT. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis 2001; 154: 497-504.
11. De Michele M, Panico S, Iannuzzi A, et al. Association of obesity and central fat distribution with carotid artery wall thickening in middle-aged women. Stroke 2002; 33: 2923-2928.
12. Oike M, Yokokawa H, Fukuda H, et al. Association between abdominal fat distribution and atherosclerotic changes in the carotid artery. Obes Res Clin Pract 2014; 8: e448-e458.
13. Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care 2004; 27: 2498-2500.
14. Petit JM, Guiu B, Terriat B, et al. Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. J Clin Endocrinol Metab 2009; 94: 4103-4106.
15. Poanta LI, Albu A, Fodor D. Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. Med Ultrason 2011; 13: 215-219.
16. Coracina A, Gaiani S, Cosma A, et al. No association between the degree of liver steatosis and early signs of vasculopathy in T2DM. Nutr Metab Cardiovasc Dis 2012; 22: e11-e12.
17. McKimmie RL, Daniel KR, Carr JJ, et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 2008; 103: 3029-3035.
18. Targher G, Bertolini L, Padovani R, et al. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. J Endocrinol Invest 2006; 29: 55-60.
19. Kim SK, Choi YJ, Huh BW, et al. Nonalcoholic Fatty liver disease is associated with increased carotid intimamedia thickness only in type 2 diabetic subjects with insulin resistance. J Clin Endocrinol Metab 2014; 99: 1879-1884.
20. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: 1-253.
21. Bugianesi E, Pagotto U, Manini R, et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 2005; 90: 3498-3504.
22. INBODY 720 USER'S MANUAL. (1996-2004 Biospace Co, Ltd. URL http://www.bodyanalyse.no/docs/720%20users%20manual.pdf.
23. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004-2006-2011). Cerebrovasc Dis 2012; 34: 290-296.
24. Staikov IN, Nedeltchev K, Arnold M, et al. Duplex sonographic criteria for measuring carotid stenoses. J Clin Ultrasound 2002; 30: 275-281.
25. Moneta GL, Edwards JM, Papanicolaou G, et al. Screening for asymptomatic internal carotid artery stenosis: duplex criteria for discriminating 60% to 99% stenosis. J Vasc Surg 1995; 21: 989-994.
26. Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357.
27. Stein JH, Korcarz CE, Hurst RT, et al; American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Ecocardiogr 2008; 21: 93-111.
28. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37: 87-92.
29. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness. a systematic review and metaanalysis. Circulation 2007; 115: 459-467.
30. Toledo FG, Sniderman AD, Kelley DE. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care 2006; 29: 1845-1850.
31. Targher G, Valbusa F, Bonapace S, et al. Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. PLoS One 2013; 8: e57183.
32. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005; 25: 1045-1050.
33. Dick TJ, Lesser IA, Leipsic JA, Mancini GB, Lear SA. The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort. Atherosclerosis 2013; 226: 208-213.
34. Slyper AH, Rosenberg H, Kabra A, et al. Early atherogenesis and visceral fat in obese adolescents. Int J Obes (Lond) 2014; 38: 954-958.
35. Bacha F, Edmundowicz D, Sutton-Tyrell K, Lee S, Tfayli H, Arslanian SA. Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants? Diabetes Care 2014; 37: 2632-2639.
36. Rallidis LS, Baroutsi K, Zolindaki M, et al. Visceral adipose tissue is a better predictor of subclinical carotid atherosclerosis compared with waist circumference. Ultrasound Med Biol 2014; 40: 1083-1088.
37. Chen LH, Zhu WF, Liang L, et al. Relationship between glycated haemoglobin and subclinical atherosclerosis in obese children and adolescents. Arch Dis Child 2014; 99: 39-45.
38. Kwak MS, Yim JY, Kim D, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcium score in diabetes patients with higher HbA1c. Diabetol Metab Syndr 2015; 28; 7:28.
39. Guiu B, Loffroy R, Hillon P, Petit JM. Magnetic resonance imaging and spectroscopy for quantification of hepatic steatosis: urgent need for standardization! J Hepatol 2009; 51: 1082-1083.
40. Guiu B, Petit JM, Loffroy R, et al. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009; 250: 95-102.
41. Lupşor-Platon M, Stefănescu H, Mureşan D, et al. Noninvasive assessment of liver steatosis using ultrasound methods. Med Ultrason 2014; 16: 236-245.
42. Badea R. Ficatul. In: Badea RI, Dudea SM, Mircea PA, Stamatian F. Tratat de Ultrasonografie Clinică. Ed. Medicală, Bucureşti, 2000: 105-176.
43. Mathiesen UL, Franzen LE, Aselius H, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002; 34: 516-522.
44. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539-543.
45. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
46. Ozhan H, Alemdar R, Caglar O, et al; MELEN Investigators. Performance of bioelectrical impedance analysis in the diagnosis of metabolic syndrome. J Investig Med 2012; 60: 587-591.
47. Völgyi E, Tylavsky FA, Lyytikäinen A, Suominen H, Alén M, Cheng S. Assessing body composition with DXA and bioimpedance: effects of obesity, physical activity, and age. Obesity (Silver Spring) 2008; 16: 700-705.
48. Pérez-Matute P, Pérez-Martínez L, Blanco JR, et al. Multiple frequency bioimpedance is an adequate tool to assess total and regional fat mass in HIV-positive patients but not to diagnose HIV-associated lipoatrophy: a pilot study. J Int AIDS Soc 2013; 16: 18609.
49. Karason K, Wikstrand J, Sjostrom L, Wendelhag I. Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects. Int J Obes Relat Metab Disord 1999; 23: 948-956.
50. Mavri A, Stegnar M, Sentocnik JT, Videcnik V. Impact of weight reduction on early carotid atherosclerosis in obese premenopausal women. Obes Res 2001; 9: 511-516.